News Quantified

CDTX – cidara therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Cidara Therapeutics, Inc. (NASDAQ: CDTX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.

Cidara Therapeutics, Inc. (NASDAQ: CDTX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.

Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.

Cidara Therapeutics GAAP EPS of -$2.38 beats by $1.87 [Seeking Alpha]

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

3.0%

BEAT

5.8%

BEAT

-6.4%

MISS

Form 8-K Cidara Therapeutics, For: Nov 07

Form 10-Q Cidara Therapeutics, For: Sep 30

Form 4 Cidara Therapeutics, For: Sep 30 Filed by: Sandison Taylor

Form 4 Cidara Therapeutics, For: Sep 30 Filed by: Tari Leslie

Form 4 Cidara Therapeutics, For: Sep 30 Filed by: Stein Jeffrey

Top News Gainers

9/3 Cidara Therapeutics and Mundipharma Form Strategic Partnership to Develop and Commercialize Rezafungin 39.9%

1/22 Form 424B5 Cidara Therapeutics, 17.9%

12/26 Cidara Therapeutics Inc (NASDAQ: CDTX) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 10.5%

3/4 Q4/2019 12/31/2019 EPS -0.420 ZacksConsensus -0.280 ActVsEst (0.140) - Miss 10.1%

1/14 Cidara Therapeutics Inc (NASDAQ: CDTX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 8.4%

6/5 Cidara Therapeutics Inc (NASDAQ: CDTX) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $6.00 price target on the stock. 8.4%

3/23 Form 4 Cidara Therapeutics, For: Mar 19 Filed by: Sandison Taylor 7.7%

6/27 Form 4 Cidara Therapeutics, For: Jun 17 Filed by: Mineo Chrysa 7.0%

8/7 Cidara Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference 6.4%

1/6 Form 4 Cidara Therapeutics, For: Jan 03 Filed by: Daruwala Paul 6.4%

Top News Decliners

9/3 Thinking about buying stock in Cidara Therapeutics, Canopy Growth, Generac, Lowe's, or Medicines Co? -22.6%

7/29 Form 8-K Cidara Therapeutics, For: Jul 29 -14.7%

9/3 Cidara Therapeutics Inc (NASDAQ: CDTX) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. -13.5%

1/13 Form 8-K Cidara Therapeutics, For: Jan 13 -10.8%

4/7 Cidara Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference -7.8%

2/21 Form SC 13G Cidara Therapeutics, Filed by: Stonepine Capital Management, LLC -7.4%

1/10 Cidara Therapeutics Announces Proposed Rights Offering -6.7%

7/29 Form 8-K Cidara Therapeutics, For: Jul 29 -6.1%

4/28 Cidara Therapeutics to Participate in Antifungal and COVID-19 Therapeutics Panels at Maxim Group’s Infectious Disease Virtual Conference -6.0%

10/1 Form 4 Cidara Therapeutics, For: Sep 27 Filed by: Oien Jessica -5.9%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day